Genasys (US:GNSS)2025-12-09 21:08Revenue Growth - Fiscal Q4 2025 revenue was $17.0 million, a 152.6% increase from $6.7 million in Q4 2024[4] - Fiscal year 2025 revenue increased by 69.8% to $40.8 million, compared to $24.0 million in fiscal year 2024[11] - Revenues for the three months ended September 30, 2025, reached $17,027 million, a significant increase from $6,741 million in the same period of 2024, representing a growth of 152.5%[26] Profitability Metrics - Gross margin for Q4 2025 was 50.3%, up from 40.8% in Q4 2024[4] - Adjusted EBITDA for Q4 2025 was $2.4 million, a significant improvement from a loss of $6.0 million in Q4 2024[7] - Adjusted EBITDA for the three months ended September 30, 2025, was $2,375 million, compared to a loss of $6,013 million in the same period of 2024[26] Operating Income and Expenses - GAAP operating income for Q4 2025 was $1.3 million, compared to a loss of $7.1 million in Q4 2024[4] - Total operating expenses decreased to $7,260 million for the three months ended September 30, 2025, down from $9,881 million in the same period of 2024, a reduction of 26.5%[26] - The company incurred other expenses of $2,680 million for the three months ended September 30, 2025, compared to $4,183 million in the same period of 2024, a decrease of 36.0%[26] Net Loss - GAAP net loss for fiscal year 2025 was $18.1 million, or $0.40 per share, compared to a loss of $31.7 million, or $0.72 per share, in fiscal year 2024[14] - The net loss for the three months ended September 30, 2025, was $1,408 million, significantly lower than the net loss of $11,386 million in the same period of 2024[26] - The company reported a loss before income taxes of $1,369 million for the three months ended September 30, 2025, compared to a loss of $11,315 million in the same period of 2024[26] Cash Position - Cash and cash equivalents totaled $7.97 million as of September 30, 2025, down from $13.1 million a year earlier[15] Future Outlook - Genasys expects sustained year-over-year revenue growth with gross margins near 50% entering fiscal 2026[4] - The company secured an additional $1.1 million in LRAD orders from the U.S. Military, indicating continued demand[7] Research and Development - Research and development expenses for the three months ended September 30, 2025, were $1,504 million, down from $2,427 million in the same period of 2024, a decrease of 38.0%[26] Share Information - The weighted average common shares outstanding for the three months ended September 30, 2025, were 45,154 million, slightly up from 44,598 million in the same period of 2024[26] Income Tax - The income tax benefit for the three months ended September 30, 2025, was $39 million, compared to an expense of $71 million in the same period of 2024[26]